Koninklijke DSM N.V.
KDSKF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $8 | $8 | $9 | $8 |
| % Growth | -9.5% | -8.8% | 13.5% | – |
| Cost of Goods Sold | $6 | $6 | $6 | $5 |
| Gross Profit | $2 | $3 | $3 | $3 |
| % Margin | 20.7% | 32.1% | 34.4% | 34.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$0 | $1 | $1 | $1 |
| % Margin | -5.4% | 8.1% | 11.1% | 8.2% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $1 | $1 | $1 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | $2 | $2 | $2 | $1 |
| % Margin | 30.5% | 20.3% | 18.2% | 6.2% |
| EPS | 13.41 | 9.8 | 9.68 | 2.91 |
| % Growth | 36.8% | 1.2% | 232.6% | – |
| EPS Diluted | 13.38 | 9.77 | 9.63 | 2.89 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | 4% | 16.4% | 15.2% | 17.7% |